Relonchem receives UK MHRA approval for its products

Marksans Pharma  announced that its wholly owned subsidiary Relonchem in UK has received Marketing Authorization for the below-mentioned products from UK MHRA:

1. Metformin Hydrochloride Relonchem 500 mg Prolonged Release Tablets
2. Metformin Hydrochloride Relonchem 750 mg Prolonged Release Tablets
3. Metformin Hydrochloride Relonchem 1000 mg Prolonged Release Tablets

Powered by Capital Market - Live News